These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8304246)

  • 1. Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine].
    Naito K; Nakajima S; Kanbayashi N; Okuyama A; Goto M
    Agents Actions; 1993 Jul; 39(3-4):182-6. PubMed ID: 8304246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor.
    Naito K; Kanbayashi N; Nakajima S; Murai T; Arakawa K; Nishimura S; Okuyama A
    Int J Cancer; 1994 Sep; 58(5):730-5. PubMed ID: 8077060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.
    Watanabe K; Yoshida D; Noha M; Teramoto A
    J Neurooncol; 2001 Mar; 52(1):1-9. PubMed ID: 11451198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CDK and MMP inhibitors].
    Okuyama A; Akiyama T; Nakajima M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1547-62. PubMed ID: 9309154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major metabolite of aceclofenac, 4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells.
    Yamazaki R; Kawai S; Mizushima Y; Matsuzaki T; Hashimoto S; Yokokura T; Ito A
    Inflamm Res; 2000 Mar; 49(3):133-8. PubMed ID: 10807502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid.
    Cawston TE; Mercer E; de Silva M; Hazleman BL
    Arthritis Rheum; 1984 Mar; 27(3):285-90. PubMed ID: 6322810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells.
    Okada Y; Konomi H; Yada T; Kimata K; Nagase H
    FEBS Lett; 1989 Feb; 244(2):473-6. PubMed ID: 2920840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption.
    Shibutani T; Yamashita K; Aoki T; Iwayama Y; Nishikawa T; Hayakawa T
    J Bone Miner Metab; 1999; 17(4):245-51. PubMed ID: 10575588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic induction by BE16627B on human malignant glioma cell lines by an anti-matrix metalloproteinase agent.
    Yoshida D; Watanabe K; Takahashi H; Sugisaki Y; Teramoto A
    Brain Tumor Pathol; 2003; 20(1):13-9. PubMed ID: 14604227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of progelatinase B in synovial fluids of patients with rheumatoid arthritis, with reference to stromelysin-1 and tissue inhibitor of matrix metalloproteinase-1.
    Watanabe Y; Yamaguchi R; IwakiEgawa S; Shimamori Y; Fujimoto Y; Matsuno H
    Clin Exp Rheumatol; 1999; 17(4):401-6. PubMed ID: 10464548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.
    Cawston TE; Bigg HF; Clark IM; Hazleman BL
    Ann Rheum Dis; 1993 Mar; 52(3):177-81. PubMed ID: 8484669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
    Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
    Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
    Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
    J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis.
    Huet G; Flipo RM; Richet C; Thiebaut C; Demeyer D; Balduyck M; Duquesnoy B; Degand P
    Clin Chem; 1992 Sep; 38(9):1694-7. PubMed ID: 1526000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a gelatinase from human rheumatoid synovial fluid cells.
    Kolkenbrock H; Ali HM; Hecker-Kia A; Buchlow G; Sörensen H; Hauer RW; Ulbrich N
    Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):499-505. PubMed ID: 1659460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the presence of dipeptidyl carboxypeptidase and its inhibitors in inflammatory synovial fluids.
    Elisseeva YE; Pavlikhina LV; Orekhovich VN; Giacomello A; Salerno C; Fasella P
    Biochim Biophys Acta; 1981 Mar; 658(1):165-8. PubMed ID: 6163469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints.
    Okada Y; Nagase H; Harris ED
    J Rheumatol; 1987 May; 14 Spec No():41-2. PubMed ID: 3305938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of matrix metalloproteinases in rheumatoid arthritis and the crystallographic binding mode of a peptide inhibitor.
    Tschesche H; Bläser J; Kleine T; Schnierer S; Reinemer P; Bode W; Maasjoshusmann U; Fricke C
    Ann N Y Acad Sci; 1994 Sep; 732():400-2. PubMed ID: 7978819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.